Individual drug particles deliver a smooth, pleasant mouthfeel, with no aftertaste
Microencapsulation par coacervation :
- Revêtement uniforme d'une particule solide ou d'une gouttelette liquide avec un polymère rigide semi-perméable
- Creates a physical barrier
- Masquage efficace du goût
- Profil de libération personnalisé
- Turn non-aqueous liquids into powders
- Combiner des API incompatibles
The final dosage forms can be produced in:
- Powders
- Dry syrups
- Comprimés à désagrégation orale
- Parvulet® dosage form: soft food-like texture
Parler avec un expert
Srinivasan Shanmugam, Docteur en médecine
Directeur principal, Sciences pharmaceutiques, soutien aux entreprises et nouvelles technologies
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
